Neuregulin-Induced ErbB3 Downregulation Is Mediated by a Protein Stability Cascade Involving the E3 Ubiquitin Ligase Nrdp1
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms underlying epidermal growth factor (EGF) receptor tyrosine kinase down-regulation in response to growth factor binding are coming into focus and involve cbl-mediated receptor ubiquitination followed by lysosomal degradation. However, mechanisms underlying the ligand-stimulated degradation of the related receptor tyrosine kinases of the ErbB family do not involve cbl and remain unexplored. Previous studies have demonstrated that the E3 ubiquitin ligase Nrdp1 contributes to the maintenance of steady-state ErbB3 levels by mediating its growth factor-independent degradation. Here we demonstrate that treatment of cells with the ErbB3 ligand neuregulin-1 (NRG1) stabilizes the deubiquitinating enzyme USP8, which in turn stabilizes Nrdp1. The catalytic activity of USP8 is required for NRG1-induced Nrdp1 stabilization. We provide evidence that Akt-mediated phosphorylation of USP8 threonine residue T907 contributes to USP8 stability. Finally, we demonstrate that Nrdp1 or USP8 knockdown suppresses NRG1-induced ErbB3 ubiquitination and degradation in MCF7 breast cancer cells. We conclude that an NRG1-induced protein stability cascade involving USP8 and Nrdp1 mediates the down-regulation of ErbB3. Our observations raise the possibility that the ligand-induced augmentation of pathways involved in the maintenance of basal levels of receptor tyrosine kinases can contribute to ligand-stimulated down-regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the rhodanese-like domain (Rhod) of USP8 is known to bind the E3 ligase, Nrdp1, and in so doing indirectly influences the degradation of Erb-B3 (33,36,37).”
From Regulation of Epidermal Growth Factor Receptor Ubiquitination and Trafficking by the USP8·STAM Complex (2010) · cites this paper as [36]
In the citing paper
“Ubiquitin-mediated protein degradation has been shown to regulate ErbB3 (Cao, 2007), but this process is on the order of several hours, which is too slow to account for the observed dynamics of ErbB3 phosphorylation.”
From Input–output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data (2009) · cites this paper as Cao, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“For example, amplification of the erbB2 gene is observed in 25 to 30% of breast cancer patients, and overexpression of the product correlates with an earlier relapse and poor prognosis (46, 47).”
BackgroundStudies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Receptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80231-2 · Cited by 1,001
Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., & Hynes, N. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537685100 · Cited by 950
Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation
Haglund, K., Sigismund, S., Polo, S., Szymkiewicz, I., Di Fiore, P. P., & Dikic, I. (2003) · Nature Cell Biology · doi:10.1038/ncb983 · Cited by 715
Alroy, I., & Yarden, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00412-2 · Cited by 714
Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity.
Guy, P. M., Platko, J. V., Cantley, L. C., Cerione, R. A., & Carraway, K. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8132 · Cited by 698 · cited 1×
“Since ErbB3 lacks intrinsic tyrosine kinase activity (16) and no diffusible ligand that binds to ErbB2 has been described, these two receptors must necessarily collaborate in propagating signals in response to growth factors such as the ErbB3 ligand neuregulin-1 (NRG1) ( 9, 48).”
BackgroundSelf-citationCoexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski, M. X., Schaefer, G., Akita, R. W., Lofgren, J. A., Fitzpatrick, V. D., Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L., & Carraway, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36676-0 · Cited by 643
Self-citationCbl: many adaptations to regulate protein tyrosine kinases
Thien, C. B. F., & Langdon, W. Y. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067100 · Cited by 625
The ErbB receptors and their role in cancer progression
Holbro, T. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00099-x · Cited by 608
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
Carraway, K. L., & Cantley, L. C. (1994) · Cell · doi:10.1016/0092-8674(94)90564-9 · Cited by 587
Self-citationCooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi, M., Romano, A., Curia, M. C., Muraro, R., Fedi, P., Aaronson, S. A., Fiore, P. P. D., & Kraus, M. H. (1995) · PubMed · Cited by 548
Neuregulin and ErbB receptor signaling pathways in the nervous system
Buonanno, A., & Fischbach, G. D. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00210-5 · Cited by 505
Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S., & Sorkin, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.018 · Cited by 497
Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis
Burden, S., & Yarden, Y. (1997) · Neuron · doi:10.1016/s0896-6273(00)80324-4 · Cited by 476
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Distinct monoubiquitin signals in receptor endocytosis
Haglund, K. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.005 · Cited by 367
Trafficking of the ErbB receptors and its influence on signaling
Wiley, H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00002-8 · Cited by 348
When ubiquitin meets ubiquitin receptors: a signalling connection
Di Fiore, P. P., Polo, S., & Hofmann, K. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1124 · Cited by 309
Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation
Mosesson, Y., Shtiegman, K., Katz, M., Zwang, Y., Vereb, G., Szollosi, J., & Yarden, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300096200 · Cited by 286
Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28238 · Cited by 284
Row, P. E., Prior, I. A., McCullough, J., Clague, M. J., & Urbé, S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512615200 · Cited by 264
Louie, M. C., Zou, J. X., Rabinovich, A., & Chen, H.-W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5157-5171.2004 · Cited by 259
Mizuno, E., Iura, T., Mukai, A., Yoshimori, T., Kitamura, N., & Komada, M. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-06-0560 · Cited by 248
Expression of the ERBB3 gene product in breast cancer
Lemoine, N., Barnes, D., Hollywood, D., Hughes, C., Smith, P., Dublin, E., Prigent, S., Gullick, W., & Hurst, H. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.420 · Cited by 234
Escape from Cbl-mediated downregulation
Peschard, P., & Park, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00136-3 · Cited by 233
Katome, T., Obata, T., Matsushima, R., Masuyama, N., Cantley, L. C., Gotoh, Y., Kishi, K., Shiota, H., & Ebina, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302094200 · Cited by 212 · cited 1×
“HA-tagged rat dominant negative Akt1 (K179M, T308A, S473A [ 24 ]) and HA-tagged constitutively active (PH-myr-Akt) human Akt1, both in the pAdTrack-CMV plasmid, were the kind gifts of Toshiyuki Obata.”
BackgroundAssociation with Membrane Protrusions Makes ErbB2 an Internalization-resistant Receptor
Hommelgaard, A. M., Lerdrup, M., & van Deurs, B. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-08-0596 · Cited by 210
de Melker, A. A., van der Horst, G., Calafat, J., Jansen, H., & Borst, J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.11.2167 · Cited by 203
Expression of c-erbB3 protein in primary breast carcinomas
Naidu, R., Yadav, M., Nair, S., & Kutty, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.689 · Cited by 190
Wang, Z., Zhang, L., Yeung, T. K., & Chen, X. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.5.1621 · Cited by 181
Oncogenic growth factor receptors: implications for signal transduction therapy
Mosesson, Y., & Yarden, Y. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.005 · Cited by 167
Bowers, K., Piper, S. C., Edeling, M. A., Gray, S. R., Owen, D. J., Lehner, P. J., & Luzio, J. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508632200 · Cited by 166
Qiu, X.-B., & Goldberg, A. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232580999 · Cited by 155
Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.
Levkowitz, G., Klapper, L. N., Tzahar, E., Freywald, A., Sela, M., & Yarden, Y. (1996) · PubMed · Cited by 154
Carraway, K. L., Soltoff, S. P., Diamonti, A. J., & Cantley, L. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7111 · Cited by 151
Self-citationStern, D. F. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00103-9 · Cited by 147
Stabilization of the E3 Ubiquitin Ligase Nrdp1 by the Deubiquitinating Enzyme USP8
Wu, X., Yen, L., Irwin, L., Sweeney, C., & Carraway, K. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7748-7757.2004 · Cited by 144
Self-citationLill, N. L., Douillard, P., Awwad, R. A., Ota, S., Lupher, M. L., Miyake, S., Meissner-Lula, N., Hsu, V. W., & Band, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.367 · Cited by 142
Longva, K. E., Pedersen, N. M., Haslekås, C., Stang, E., & Madshus, I. H. (2005) · International Journal of Cancer · doi:10.1002/ijc.21015 · Cited by 142
An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels
Diamonti, A. J., Guy, P. M., Ivanof, C., Wong, K., Sweeney, C., & Carraway, K. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052709799 · Cited by 126
Self-citationThe type I growth factor receptors in human breast cancer
Rajkumar, T., & Gullick, W. J. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666177 · Cited by 123
ErbB2 Pathways in Heart and Neural Diseases
Garratt, A. N., Özcelik, C., & Birchmeier, C. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00231-1 · Cited by 122
A Deubiquitinating Enzyme UBPY Regulates the Level of Protein Ubiquitination on Endosomes
Mizuno, E., Kobayashi, K., Yamamoto, A., Kitamura, N., & Komada, M. (2006) · Traffic · doi:10.1111/j.1600-0854.2006.00452.x · Cited by 120
Ravid, T., Sweeney, C., Gee, P., Carraway, K. L., & Goldkorn, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204677200 · Cited by 106
Self-citationLoss of Nrdp1 Enhances ErbB2/ErbB3–Dependent Breast Tumor Cell Growth
Yen, L., Cao, Z., Wu, X., Ingalla, E., Baron, C. A., Young, L. J. T., Gregg, J. P., Cardiff, R. D., Borowsky, A. D., Sweeney, C. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2319 · Cited by 93
Self-citationFunes, M., Miller, J. K., Lai, C., Carraway, K. L., & Sweeney, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603225200 · Cited by 88
Self-citationThe role of ubiquitylation in signaling by growth factors: implications to cancer
Shtiegman, K., & Yarden, Y. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00097-4 · Cited by 85
Hijazi, M., Thompson, E. W., Tang, C., Coopman, P. J., Torri, J. A., Yang, D. C. H., Mueller, S. C., & Lupu, R. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.4.629 · Cited by 69
Boyer, C., Xu, F. J., Mills, G., O'Briant, K. C., Bast, R. C., Jr., Whitaker, R., Stack, S., & Yu, Y. H. (2022) · PubMed · doi:10.7274/24742149 · Cited by 66
Negative regulation of ErbB family receptor tyrosine kinases
Sweeney, C., & Carraway, K. L. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601500 · Cited by 55
Self-citationHeregulin Degradation in the Absence of Rapid Receptor-Mediated Internalization
Baulida, J., & Carpenter, G. F. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3515 · Cited by 43
Cell morphogenesis in Arabidopsis
Hülskamp, M., Folkers, U., & Grini, P. E. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<20::aid-bies5>3.0.co;2-w · Cited by 30
ErbB Receptor Negative Regulatory Mechanisms: Implications in Cancer
Sweeney, C. A., Miller, J. K., Shattuck, D. L., & Carraway, K. L. (2006) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9015-3 · Cited by 19
Self-citation
Research works printed but not linked: 1
- 42. Riese, D. J., II, and D. F. Stern. 1998. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20: 41-48. · DOI · Paper page
Cited by
Breaking the chains: structure and function of the deubiquitinases
Komander, D., Clague, M. J., & Urbé, S. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2731 · Cited by 1,969
Endocytosis and intracellular trafficking of ErbBs
Sorkin, A., & Goh, L. K. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.07.029 · Cited by 756
Endocytosis of Receptor Tyrosine Kinases
Goh, L. K., & Sorkin, A. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a017459 · Cited by 461
Deubiquitinases in cancer: new functions and therapeutic options
Fraile, J. M., Quesada, V, Rodríguez, D., Freije, J. M. P., & López-Otín, C. (2012) · Oncogene · doi:10.1038/onc.2011.443 · Cited by 453
Chen, W. W., Schoeberl, B., Jasper, P. J., Niepel, M., Nielsen, U. B., Lauffenburger, D. A., & Sorger, P. K. (2009) · Molecular Systems Biology · doi:10.1038/msb.2008.74 · Cited by 391
Metadata
- Authors
- Cao, Z., Wu, X., Yen, L., Sweeney, C., & Carraway, K. L.
- Affiliations
- UC Davis Comprehensive Cancer Center (US)
- Corresponding author
- Carraway, Kermit L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-03-01
- Volume
- 27
- Issue
- 6
- Pages
- 2180-2188
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC1820496
- OpenAlex
- W2149674434
- Cited by
- 119
- References
- 57
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 4
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (GM068994, CA118384)
- National Cancer Institute (CA123541, R01CA118384, R01CA123541, CA118384)
- National Institute of General Medical Sciences (R01GM068994, GM068994)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- neuregulin-1, HER3, Nrdp1, USP8, deubiquitinase, protein stability, receptor degradation, E3 ubiquitin ligase, Akt phosphorylation, MCF-7 cells, ubiquitination
- MeSH terms
- Animals, Cell Line, Chlorocebus aethiops, Humans, Endopeptidases, Phosphothreonine, Protein Binding, Signal Transduction, Down-Regulation, Phosphatidylinositol 3-Kinases, Neuregulin-1, Receptor, ErbB-3, Ubiquitin, Ubiquitin Thiolesterase, Ubiquitin-Protein Ligases, Proto-Oncogene Proteins c-akt, Endosomal Sorting Complexes Required for Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.